alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Mary Beth DeLena
Vice President and Associate General Counsel, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Ms. Mary Beth DeLena serves as Vice President and Associate General Counsel at Alnylam Pharmaceuticals, Inc. Ms. DeLena served as Senior Director of Legal of Alnylam Pharmaceuticals, Inc. She served as a Secretary of Praecis Pharmaceuticals Inc.
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|